BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30921263)

  • 1. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
    Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
    J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
    Brunstein CG; Miller JS; Cao Q; McKenna DH; Hippen KL; Curtsinger J; Defor T; Levine BL; June CH; Rubinstein P; McGlave PB; Blazar BR; Wagner JE
    Blood; 2011 Jan; 117(3):1061-70. PubMed ID: 20952687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.
    McKenna DH; Sumstad D; Kadidlo DM; Batdorf B; Lord CJ; Merkel SC; Koellner CM; Curtsinger JM; June CH; Riley JL; Levine BL; Miller JS; Brunstein CG; Wagner JE; Blazar BR; Hippen KL
    Cytotherapy; 2017 Feb; 19(2):250-262. PubMed ID: 27887864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
    Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
    Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
    Parmar S; Liu X; Tung SS; Robinson SN; Rodriguez G; Cooper LJ; Yang H; Shah N; Yang H; Konopleva M; Molldrem JJ; Garcia-Manero G; Najjar A; Yvon E; McNiece I; Rezvani K; Savoldo B; Bollard CM; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):90-100. PubMed ID: 24480547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
    Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
    Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
    Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
    Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.
    Guo H; Zhang H; Lu L; Ezzelarab MB; Thomson AW
    Cell Immunol; 2015 May; 295(1):19-28. PubMed ID: 25732601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple unit pooled umbilical cord blood is a viable source of therapeutic regulatory T cells.
    Milward K; Issa F; Hester J; Figueroa-Tentori D; Madrigal A; Wood KJ
    Transplantation; 2013 Jan; 95(1):85-93. PubMed ID: 23263503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis.
    Huang H; Deng Z
    Biochem Biophys Res Commun; 2019 Apr; 512(1):14-21. PubMed ID: 30853178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage
    Issa F; Milward K; Goto R; Betts G; Wood KJ; Hester J
    Front Immunol; 2019; 10():889. PubMed ID: 31068951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct expansion of human allospecific FoxP3+CD4+ regulatory T cells with allogeneic B cells for therapeutic application.
    Chen LC; Delgado JC; Jensen PE; Chen X
    J Immunol; 2009 Sep; 183(6):4094-102. PubMed ID: 19684083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.